Please Note:
This profile was automatically generated using 155 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 155 references found on the Internet. This information has not been verified. Learn more...
View all 155 references Web References
-
1. McGill Department of Neurology
neurology.mcgill.ca/faculty.ht - [Cached]Published on: 7/25/2008 Last Visited: 7/25/2008
Jean Pierre Roy -
2. McGill Department of Neurology
www.neurology.mcgill.ca/roy_jp - [Cached]Published on: 10/24/2006 Last Visited: 10/24/2006
Jean Pierre Roy, MD
McGill title: Assistant Professor -
3. ALSA Presents 2000 Sheila Essey Award for ALS Research - The ALS Association
secure.alsa.org/news/article.c - [Cached]Published on: 5/2/2000 Last Visited: 12/8/2007
The ALS Association will join the American Academy of Neurology in presenting The 2000 Sheila Essey Award for ALS Research to Jean Pierre Julien, Ph.D. at the Academy's 52nd Annual Meeting in San Diego, California on Tuesday, May 2nd.Dr. Julien is associate professor of neurology at McGill University, Montreal, Canada, and a research professor at the Montreal General Hospital Research Institute.
...
The award is being presented to Dr. Julien for his work in ALS research to advance the understanding of this devastating disease.His research, "Transgenic Mice the Overproduce Peripherin: New Mouse Models of Motor Neuron Disease," conducted on genetically altered mice, suggests that peripherin, a protein detected in the majority of cells affected with amyotrophic lateral sclerosis (ALS), may be a major contributor to the debilitating symptoms of the disease.Dr. Julien will receive a $25,000 prize, funded by a grant from the Essey family, to be used for continuing his ALS research.
Adds Mr. Essey "I am so hopeful that Dr. Julien's research, to date and in the future, will help others unlock the secret as to what causes ALS and how to cure it."
...
Julien's work clearly moves us closer to finding not only the cause of ALS, but the development of treatments for this disease."

